nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxamine—ADRA1D—polycystic ovary syndrome	0.373	0.412	CbGaD
Methoxamine—ADRA1B—polycystic ovary syndrome	0.318	0.351	CbGaD
Methoxamine—ADRA1A—polycystic ovary syndrome	0.214	0.237	CbGaD
Methoxamine—Midodrine—ADRA1D—polycystic ovary syndrome	0.00195	0.29	CrCbGaD
Methoxamine—Midodrine—ADRA1B—polycystic ovary syndrome	0.00166	0.247	CrCbGaD
Methoxamine—Metaraminol—ADRA1A—polycystic ovary syndrome	0.00137	0.204	CrCbGaD
Methoxamine—Midodrine—ADRA1A—polycystic ovary syndrome	0.00112	0.166	CrCbGaD
Methoxamine—Levonordefrin—ADRA1A—polycystic ovary syndrome	0.000623	0.0926	CrCbGaD
Methoxamine—ADRA1D—GPCR downstream signaling—FSHR—polycystic ovary syndrome	6.77e-05	0.000767	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PDE3B—polycystic ovary syndrome	6.75e-05	0.000765	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	6.71e-05	0.00076	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	6.66e-05	0.000755	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PTAFR—polycystic ovary syndrome	6.52e-05	0.000739	CbGpPWpGaD
Methoxamine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	6.44e-05	0.000729	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	6.38e-05	0.000723	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	6.33e-05	0.000717	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	6.21e-05	0.000703	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	6.19e-05	0.000702	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	6.19e-05	0.000702	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	6.19e-05	0.000702	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	6.19e-05	0.000702	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	6.17e-05	0.000699	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—FSHR—polycystic ovary syndrome	6.15e-05	0.000697	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	6.03e-05	0.000683	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	5.96e-05	0.000675	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NPB—polycystic ovary syndrome	5.95e-05	0.000674	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—LHB—polycystic ovary syndrome	5.89e-05	0.000667	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	5.79e-05	0.000656	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	5.76e-05	0.000652	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—GHRL—polycystic ovary syndrome	5.71e-05	0.000647	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—ADRB2—polycystic ovary syndrome	5.7e-05	0.000645	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FLT4—polycystic ovary syndrome	5.65e-05	0.00064	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	5.62e-05	0.000637	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	5.62e-05	0.000637	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—FSHR—polycystic ovary syndrome	5.62e-05	0.000637	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PDE3B—polycystic ovary syndrome	5.6e-05	0.000635	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—SCT—polycystic ovary syndrome	5.52e-05	0.000625	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	5.52e-05	0.000625	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	5.48e-05	0.000621	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	5.47e-05	0.00062	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—ADRB3—polycystic ovary syndrome	5.41e-05	0.000613	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	5.38e-05	0.000609	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—LHB—polycystic ovary syndrome	5.35e-05	0.000606	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—GNAS—polycystic ovary syndrome	5.28e-05	0.000598	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	5.27e-05	0.000597	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—GNRH1—polycystic ovary syndrome	5.23e-05	0.000592	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	5.14e-05	0.000582	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—FSHR—polycystic ovary syndrome	5.1e-05	0.000578	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—GHRL—polycystic ovary syndrome	5.07e-05	0.000575	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FLT4—polycystic ovary syndrome	5.02e-05	0.000568	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—SCT—polycystic ovary syndrome	5.01e-05	0.000568	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	4.99e-05	0.000566	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	4.98e-05	0.000564	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PTGER3—polycystic ovary syndrome	4.96e-05	0.000562	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—LHCGR—polycystic ovary syndrome	4.96e-05	0.000562	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	4.95e-05	0.000561	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NPB—polycystic ovary syndrome	4.94e-05	0.000559	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—LHB—polycystic ovary syndrome	4.89e-05	0.000554	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	4.78e-05	0.000542	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	4.78e-05	0.000541	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—ADRB2—polycystic ovary syndrome	4.73e-05	0.000536	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	4.67e-05	0.000529	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	4.67e-05	0.000529	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PTAFR—polycystic ovary syndrome	4.64e-05	0.000526	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—SCT—polycystic ovary syndrome	4.58e-05	0.000519	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—FSHR—polycystic ovary syndrome	4.53e-05	0.000514	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—ADRB3—polycystic ovary syndrome	4.49e-05	0.000509	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	4.46e-05	0.000506	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—LHB—polycystic ovary syndrome	4.44e-05	0.000503	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	4.4e-05	0.000498	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—GNAS—polycystic ovary syndrome	4.38e-05	0.000497	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NPB—polycystic ovary syndrome	4.38e-05	0.000497	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ADRA1B—polycystic ovary syndrome	4.38e-05	0.000497	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	4.37e-05	0.000495	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	4.34e-05	0.000492	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—GNRH1—polycystic ovary syndrome	4.34e-05	0.000492	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—INHBB—polycystic ovary syndrome	4.27e-05	0.000484	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	4.25e-05	0.000481	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	4.2e-05	0.000476	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—SCT—polycystic ovary syndrome	4.16e-05	0.000471	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PTGER3—polycystic ovary syndrome	4.12e-05	0.000467	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—LHCGR—polycystic ovary syndrome	4.12e-05	0.000467	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	4.07e-05	0.000461	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	3.99e-05	0.000452	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.99e-05	0.000452	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	3.97e-05	0.00045	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	3.97e-05	0.000449	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—LHB—polycystic ovary syndrome	3.94e-05	0.000447	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	3.89e-05	0.000441	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.89e-05	0.000441	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	3.88e-05	0.00044	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.88e-05	0.000439	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	3.86e-05	0.000437	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.85e-05	0.000437	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.74e-05	0.000424	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—SCT—polycystic ovary syndrome	3.7e-05	0.000419	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	3.66e-05	0.000415	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	3.66e-05	0.000415	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FSHR—polycystic ovary syndrome	3.63e-05	0.000412	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—POMC—polycystic ovary syndrome	3.56e-05	0.000403	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—INHBB—polycystic ovary syndrome	3.55e-05	0.000402	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.53e-05	0.0004	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	3.53e-05	0.000399	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.44e-05	0.00039	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.42e-05	0.000388	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.42e-05	0.000387	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.32e-05	0.000376	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.32e-05	0.000376	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.31e-05	0.000375	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FST—polycystic ovary syndrome	3.24e-05	0.000367	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.23e-05	0.000366	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.23e-05	0.000366	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.22e-05	0.000365	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.2e-05	0.000362	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—LHB—polycystic ovary syndrome	3.16e-05	0.000358	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—INHBB—polycystic ovary syndrome	3.15e-05	0.000357	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.09e-05	0.00035	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FSHR—polycystic ovary syndrome	3.02e-05	0.000342	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.99e-05	0.000339	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.99e-05	0.000338	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SCT—polycystic ovary syndrome	2.96e-05	0.000335	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—POMC—polycystic ovary syndrome	2.95e-05	0.000334	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.94e-05	0.000333	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.93e-05	0.000332	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.92e-05	0.000331	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	2.87e-05	0.000325	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.84e-05	0.000321	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.83e-05	0.00032	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FGF18—polycystic ovary syndrome	2.78e-05	0.000315	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.76e-05	0.000312	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—RBP4—polycystic ovary syndrome	2.75e-05	0.000312	CbGpPWpGaD
Methoxamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.74e-05	0.000311	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.71e-05	0.000307	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FST—polycystic ovary syndrome	2.69e-05	0.000304	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	2.68e-05	0.000303	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.67e-05	0.000303	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.65e-05	0.000301	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—LHB—polycystic ovary syndrome	2.62e-05	0.000297	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	2.62e-05	0.000297	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.6e-05	0.000295	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—YAP1—polycystic ovary syndrome	2.57e-05	0.000291	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.56e-05	0.00029	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GAB1—polycystic ovary syndrome	2.54e-05	0.000287	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.52e-05	0.000285	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.48e-05	0.000281	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.48e-05	0.000281	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SCT—polycystic ovary syndrome	2.46e-05	0.000278	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.43e-05	0.000275	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—INSR—polycystic ovary syndrome	2.42e-05	0.000275	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	2.39e-05	0.00027	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.37e-05	0.000269	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.36e-05	0.000267	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.34e-05	0.000266	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	2.33e-05	0.000264	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FGF18—polycystic ovary syndrome	2.3e-05	0.000261	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.3e-05	0.000261	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—RBP4—polycystic ovary syndrome	2.29e-05	0.000259	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.28e-05	0.000258	CbGpPWpGaD
Methoxamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.28e-05	0.000258	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.27e-05	0.000257	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.25e-05	0.000255	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PGR—polycystic ovary syndrome	2.24e-05	0.000254	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.21e-05	0.00025	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.2e-05	0.000249	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	2.18e-05	0.000247	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.16e-05	0.000244	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—YAP1—polycystic ovary syndrome	2.13e-05	0.000242	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GAB1—polycystic ovary syndrome	2.1e-05	0.000238	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GHRL—polycystic ovary syndrome	2.09e-05	0.000236	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PLAT—polycystic ovary syndrome	2.09e-05	0.000236	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.08e-05	0.000236	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	2.05e-05	0.000232	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	2.03e-05	0.00023	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.02e-05	0.000229	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—INSR—polycystic ovary syndrome	2.01e-05	0.000228	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.01e-05	0.000228	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2e-05	0.000226	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ATF1—polycystic ovary syndrome	1.99e-05	0.000225	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.94e-05	0.00022	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.93e-05	0.000219	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.91e-05	0.000217	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.89e-05	0.000215	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.88e-05	0.000213	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.87e-05	0.000212	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PGR—polycystic ovary syndrome	1.86e-05	0.000211	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NGFR—polycystic ovary syndrome	1.84e-05	0.000208	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—POMC—polycystic ovary syndrome	1.83e-05	0.000207	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PRL—polycystic ovary syndrome	1.82e-05	0.000206	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.79e-05	0.000202	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.75e-05	0.000199	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PLAT—polycystic ovary syndrome	1.73e-05	0.000196	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GHRL—polycystic ovary syndrome	1.73e-05	0.000196	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.73e-05	0.000196	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.7e-05	0.000192	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.67e-05	0.000189	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.67e-05	0.000189	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.65e-05	0.000187	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.65e-05	0.000187	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.61e-05	0.000183	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.6e-05	0.000182	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GNAS—polycystic ovary syndrome	1.6e-05	0.000181	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.54e-05	0.000174	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.54e-05	0.000174	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.53e-05	0.000173	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.52e-05	0.000173	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.52e-05	0.000172	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	1.51e-05	0.000171	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NRG1—polycystic ovary syndrome	1.5e-05	0.00017	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.48e-05	0.000168	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.47e-05	0.000166	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.46e-05	0.000165	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.43e-05	0.000162	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.43e-05	0.000162	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.42e-05	0.000161	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.35e-05	0.000153	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.35e-05	0.000152	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.34e-05	0.000152	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.33e-05	0.000151	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.29e-05	0.000147	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IRS2—polycystic ovary syndrome	1.28e-05	0.000145	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.27e-05	0.000144	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.27e-05	0.000143	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—LEP—polycystic ovary syndrome	1.26e-05	0.000142	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.24e-05	0.000141	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.18e-05	0.000134	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.12e-05	0.000127	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IRS1—polycystic ovary syndrome	1.12e-05	0.000127	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.1e-05	0.000125	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—POMC—polycystic ovary syndrome	1.08e-05	0.000122	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—INS—polycystic ovary syndrome	1.07e-05	0.000121	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.06e-05	0.000121	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	1.04e-05	0.000118	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	1.04e-05	0.000117	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	1.04e-05	0.000117	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.85e-06	0.000112	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	9.46e-06	0.000107	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	9.29e-06	0.000105	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	9.25e-06	0.000105	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	8.95e-06	0.000101	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	8.9e-06	0.000101	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	8.61e-06	9.75e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	8.6e-06	9.75e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	8.26e-06	9.35e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.18e-06	9.26e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	7.95e-06	9.01e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	7.93e-06	8.99e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	7.91e-06	8.96e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	7.65e-06	8.66e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	7.64e-06	8.66e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.26e-06	8.23e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.78e-06	7.67e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	6.58e-06	7.46e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	5.85e-06	6.62e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.62e-06	6.37e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.99e-06	5.66e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	4.69e-06	5.31e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	3.89e-06	4.41e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	3.45e-06	3.91e-05	CbGpPWpGaD
